Our data are in line with other studies in which a higher representation of activated (CD69+) interferon-γ-producing CD4+ T-lymphocytes was detected in hospitalised COVID-19 patients with pneumonia [23]. The gene discussed is CD69; the disease is susceptibility to pneumonia measurement.